{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:16:04Z","timestamp":1790169364146,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ijcard.2019.05.063","type":"journal-article","created":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T01:37:39Z","timestamp":1558661859000},"page":"39-44","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"C","title":["Trimetazidine in cardiovascular medicine"],"prefix":"10.1016","volume":"293","author":[{"given":"Mario","family":"Marzilli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragos","family":"Vinereanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Lopaschuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamshed J.","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Danchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El","family":"Etriby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Henrique","family":"Gowdak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Lopatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davor","family":"Milicic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Parkhomenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar","family":"Seferovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe M.C.","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.05.063_bb0005","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy","volume":"368","author":"Libby","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0010","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jacc.2012.02.082","article-title":"Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!","volume":"60","author":"Marzilli","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0015","article-title":"Prevalence of obstructive coronary disease in ambulatory patients with stable angina pectoris","author":"Westermann","year":"2015","journal-title":"J. Clin. Exp. Cardiol."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0020","first-page":"1","article-title":"Mechanisms and diagnostic evaluation of persistent or recurrent angina following percutaneous coronary revascularization","volume":"0","author":"Crea","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0025","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamainternmed.2013.12855","article-title":"Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials","volume":"174","author":"Stergiopoulos","year":"2014","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0030","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijcard.2017.07.105","article-title":"Angina after percutaneous coronary intervention: the need for precision medicine","volume":"248","author":"Niccoli","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"00","key":"10.1016\/j.ijcard.2019.05.063_bb0035","first-page":"1","article-title":"Meta-analysis of long-term outcomes of percutaneous coronary intervention versus medical therapy in stable coronary artery diesease","volume":"0","author":"Khan","year":"2018","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2019.05.063_bb0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10557-016-6677-y","article-title":"Pharmacological agents targeting miocardial metabolism for the management of stable angina: an update","volume":"30","author":"Guarini","year":"2016","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0045","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1053\/euhj.1999.2439","volume":"21","year":"2000","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0050","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1053\/euhj.2000.2489","article-title":"About EMIP-FR and reperfusion damage in AMI: a comment to the comment","volume":"22","author":"Marzilli","year":"2001","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0055","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/ehjcvp\/pvv051","article-title":"The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent","volume":"2","author":"McCarthy","year":"2016","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0060","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/hrt.2010.208751","article-title":"Trimetazidine: a meta-analysis of randomised controlled trials in heart failure","volume":"97","author":"Gao","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/cvr\/cvr038","article-title":"Modulating fatty acid oxidation in heart failure","volume":"90","author":"Lionetti","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0070","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jacc.2011.11.027","article-title":"Additional use of trimetazidine in patients with chronic heart failure: a meta-analysis","volume":"59","author":"Zhang","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0075","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00044011-199713010-00002","article-title":"Antianginal efficacy of the combination of trimetazidine-propranolol compared with isosorbide dinitrate-propranolol in patients with stable angina","volume":"13","author":"Michaelides","year":"1997","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00019501-200304000-00010","article-title":"Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials","volume":"14","author":"Marzilli","year":"2003","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00045391-200501000-00006","article-title":"Trimetazidine in Angina Combination Therapy\u2014the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study","volume":"12","author":"Chazov","year":"2005","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00129784-200505050-00005","article-title":"Treatment of stable angina pectoris with trimetazidine modified release in Indian primary-care practice","volume":"5","author":"Gupta","year":"2005","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0095","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000332369","article-title":"Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis","volume":"120","author":"Danchin","year":"2011","journal-title":"Cardiology"},{"issue":"1","key":"10.1016\/j.ijcard.2019.05.063_bb0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI62874","article-title":"Myocardial ischemia-reperfusion injury: a neglected therapeutic target","volume":"123","author":"Yellon","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0105","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5273(00)00443-5","article-title":"A randomized double-blind trial of intravenous trimetazidine as adjunctive therapy to primary angioplasty for acute myocardial infarction","volume":"77","author":"Steg","year":"2001","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0110","first-page":"58","article-title":"Cardioprotective effects of oral trimetazidine in diabetic patients with anterior wall myocardial infarction treated with thrombolysis","volume":"5","author":"Shehata","year":"2014","journal-title":"Cardiol. Res."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0115","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1159\/000446640","article-title":"Efficacy and safety of adjunctive trimetazidine therapy for acute myocardial infarction: a systematic review and meta-analysis","volume":"135","author":"Li","year":"2016","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0120","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.1532\/HSF98.20081133","article-title":"Trimetazidine may protect the myocardium during cardiac surgery","volume":"12","author":"Iskesen","year":"2009","journal-title":"Heart Surg. Forum"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0125","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/hrt.2006.107524","article-title":"Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention","volume":"93","author":"Bonello","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.amjcard.2014.04.052","article-title":"TMZ reducers myocardial injury in diabetic IHD patients undergoing PCI","volume":"114","author":"Shehata","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40261-014-0170-9","volume":"34","author":"Xu","year":"2014","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000375289","article-title":"The effectiveness of preoperative trimetazidine on myocardial preservation in coronary artery bypass graft patients: a systematic review and meta-analysis","volume":"131","author":"Zhang","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijcard.2006.08.082","article-title":"Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease","volume":"120","author":"Marazzi","year":"2007","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/FJC.0b013e31817bdd66","article-title":"Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy","volume":"51","author":"Belardinelli","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"11","key":"10.1016\/j.ijcard.2019.05.063_rf0155","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.ajem.2017.05.024","article-title":"The effect of trimetazidine treatment in patients with type 2 diabetes undergoing percutaneous coronary intervention for AMI32","volume":"35","author":"Li","year":"2017","journal-title":"Am. J. Emerg. Med."},{"key":"10.1016\/j.ijcard.2019.05.063_rf0160","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/CIRCHEARTFAILURE.109.888479","article-title":"Analysis of metabolic remodeling in compensated left ventricular hypertrophy and heart failure","volume":"3","author":"Kato","year":"2010","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0160","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacc.2006.03.060","article-title":"A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure","volume":"48","author":"Fragasso","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0165","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.108.778019","article-title":"Trimetazidine, a metabolic modulator, has cardiac and extracardiac benefits in idiopathic dilated cardiomyopathy","volume":"118","author":"Tuunanen","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0170","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.lfs.2012.03.015","article-title":"The effect of trimetazidine on cardiac function in diabetic patients with idiopathic dilated cardiomyopathy","volume":"92","author":"Zhao","year":"2013","journal-title":"Life Sci."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0175","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000375288","article-title":"The effect of trimetazidine added to pharmacological treatment on all-cause mortality in patients with systolic heart failure","volume":"131","author":"Grajek","year":"2015","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0180","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1161\/01.CIR.99.17.2261","article-title":"Diastolic dysfunction in hypertensive heart disease is associated with altered myocardial metabolism","volume":"99","author":"Lamb","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0185","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.jacc.2009.05.012","article-title":"Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency","volume":"54","author":"Phan","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124844","article-title":"Metabolomic fingerprint of heart failure with preserved ejection fraction","volume":"10","author":"Zordoky","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0195","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0200","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","article-title":"The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase","volume":"86","author":"Kantor","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0205","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1161\/01.RES.0000086964.07404.A5","article-title":"Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase","volume":"93","author":"Lopaschuk","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0210","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0008-6363(00)00136-X","article-title":"Changes in intracellular sodium and pH during ischaemia-reperfusion are attenuated by trimetazidine. Comparison between low- and zero-flow ischaemia","volume":"47","author":"El Banani","year":"2000","journal-title":"Cardiovasc. Res."},{"issue":"19","key":"10.1016\/j.ijcard.2019.05.063_bb0215","first-page":"6545","volume":"22","author":"Golino","year":"2018","journal-title":"Microvascular ischemia in patients with successful percutaneous coronary intervention: effects of ranolazine and isosorbide-5-mononitrate Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0220","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0225","unstructured":"Weintraub, Effect of coronary anatomy and myocardial ischemia on long term survival in patients with stable ischemic heart disease, Circ. Cardiovsc. Qual. Outcomes 118.005079."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0230","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa0907272","article-title":"Low diagnostic yield of elective coronary angiography","volume":"362","author":"Patel","year":"2010","journal-title":"NEJM"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0235","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/CIRCULATIONAHA.111.039255","volume":"124","author":"Cheng","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.05.063_bb0240","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ccd.26365","article-title":"Angina and associated healthcare costs following percutaneous coronary intervention: a real-world analysis from a multi-payer database","volume":"88","author":"Ben-Yehuda","year":"2016","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2019.05.063_bb0245","article-title":"Prognostic impact of periprocedural MI in patients undergoing elective PCI","volume":"12","author":"Koskinas","year":"2018","journal-title":"Circ. Cardiovasc. Interv."}],"updated-by":[{"DOI":"10.1016\/j.ijcard.2020.06.027","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319304103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319304103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T17:18:32Z","timestamp":1590081512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319304103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":50,"alternative-id":["S0167527319304103"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.05.063","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ijcard.2020.06.027","asserted-by":"object"}]},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trimetazidine in cardiovascular medicine","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.05.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}